Latest News about RVNC
Recent news which mentions RVNC
The Week Ahead In Biotech: Hematology Conference Gets Underway, Vanda And BioCryst Await FDA Decisions
November 29, 2020
From Benzinga
Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates
November 28, 2020
From Benzinga
The Daily Biotech Pulse: Revance's DAXI Regulatory Decision, Reata Slips On FDA Feedback, Liquidia Setback
November 25, 2020
From Benzinga
The Week Ahead In Biotech: Moderna Vaccine And Roche, Revance, Rhythm, Liquidia FDA Updates
November 22, 2020
From Benzinga
From Benzinga
12 Healthcare Stocks Moving In Monday's After-Market Session
November 09, 2020
From Benzinga
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
November 08, 2020
From Benzinga
From Benzinga
10 Biggest Price Target Changes For Thursday
October 15, 2020
From Benzinga
The Daily Biotech Pulse: Moderna Inks 2 R&D Deals, BioNTech To Buy Manufacturing Facility, Dyne Therapeutics IPO
September 17, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
September 16, 2020
From Benzinga
The Daily Biotech Pulse: Moderna Expands Into Switzerland, Tiziana To Spin Off Testing Unit, Metacrine IPO
September 16, 2020
From Benzinga
60 Biggest Movers From Yesterday
September 16, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
September 15, 2020
From Benzinga
The Daily Biotech Pulse: Sanofi, Regeneron Drop COVID-19 Study, 2 Positive AstraZeneca Catalysts, Brickell Awarded Japanese Patent
September 01, 2020
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
August 26, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
August 25, 2020
From Benzinga
From Benzinga
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
August 02, 2020
From Benzinga
The Week Ahead In Biotech (June 28- July 4): Pending Clinical Readouts In Focus During A Short Holiday Week
June 28, 2020
From Benzinga
Tickers
RVNC
From Motley Fool
From Benzinga
Revance Therapeutics (RVNC) Q4 2019 Earnings Call Transcript
February 24, 2020
Tickers
RVNC
From Motley Fool
The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace
February 23, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Friday
February 21, 2020
From Benzinga
The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion
February 21, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
February 20, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.